当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析 - 现金流量表

百洋医药

(301015)

  

流通市值:133.44亿  总市值:133.46亿
流通股本:5.26亿   总股本:5.26亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,036,901,276.734,418,769,007.922,244,391,700.748,301,581,715.21
  收到的税费返还945,035.24---
  收到其他与经营活动有关的现金77,010,628.4653,338,736.029,569,817.25138,096,365.7
  经营活动现金流入小计6,114,856,940.434,472,107,743.942,253,961,517.998,439,678,080.91
  购买商品、接受劳务支付的现金3,861,911,380.413,039,804,569.871,597,214,977.614,745,735,338.44
  支付给职工以及为职工支付的现金528,052,940.02356,536,238.98213,966,925.35707,241,369.1
  支付的各项税费420,431,316.37295,388,067.91116,082,734.08641,347,842.61
  支付其他与经营活动有关的现金1,108,019,715.07742,371,408.37303,780,054.341,410,899,925.9
  经营活动现金流出小计5,918,415,351.874,434,100,285.132,231,044,691.387,505,224,476.05
  经营活动产生的现金流量净额196,441,588.5638,007,458.8122,916,826.61934,453,604.86
二、投资活动产生的现金流量:
  收回投资收到的现金337,470,433.03207,461,562.887,461,562.8340,000,000
  取得投资收益收到的现金4,306,543.493,794,436.04602,436.727,701,860.3
  处置固定资产、无形资产和其他长期资产收回的现金净额7,1002,5002,500402,699.4
  投资活动现金流入小计341,784,076.52211,258,498.8488,066,499.52348,104,559.7
  购建固定资产、无形资产和其他长期资产支付的现金128,481,376.3987,041,084.8546,316,225.16288,930,824.87
  投资支付的现金602,330,962.51459,222,976.16229,686,883.89647,979,490.24
  投资活动现金流出小计730,812,338.9546,264,061.01276,003,109.05936,910,315.11
  投资活动产生的现金流量净额-389,028,262.38-335,005,562.17-187,936,609.53-588,805,755.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,170,783.889,170,783.88-980,000
  其中:子公司吸收少数股东投资收到的现金9,170,783.889,170,783.88-980,000
  取得借款收到的现金2,473,180,999.442,087,670,255.941,010,989,043.512,287,551,589.53
  收到其他与筹资活动有关的现金85,259,743.96160,690,920.18101,026,990.31199,285,074.98
  筹资活动现金流入小计2,567,611,527.282,257,531,9601,112,016,033.822,487,816,664.51
  偿还债务支付的现金1,981,150,684.561,627,068,281.28574,376,957.581,260,341,663.76
  分配股利、利润或偿付利息支付的现金392,249,174.5346,497,846.5218,497,855.82502,768,596.16
  其中:子公司支付给少数股东的股利、利润27,771,098.33315,000315,00035,197,963.65
  支付其他与筹资活动有关的现金204,527,926.39190,638,414.7413,638,530.75359,227,598.78
  筹资活动现金流出小计2,577,927,785.452,164,204,542.54606,513,344.152,122,337,858.7
  筹资活动产生的现金流量净额-10,316,258.1793,327,417.46505,502,689.67365,478,805.81
四、汇率变动对现金及现金等价物的影响-12,350,709.13-9,515,962.26-4,424,046.32-9,730,307.46
五、现金及现金等价物净增加额-215,253,641.12-213,186,648.16336,058,860.43701,396,347.8
  加:期初现金及现金等价物余额1,923,942,541.851,923,942,541.851,923,942,541.851,222,546,194.05
  期末现金及现金等价物余额1,708,688,900.731,710,755,893.692,260,001,402.281,923,942,541.85
补充资料:
  净利润-279,948,368.1-571,929,272.87
  资产减值准备-9,402,741.89-54,727,812.82
  固定资产和投资性房地产折旧-33,124,868.16-62,929,049.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,124,868.16-62,929,049.04
  无形资产摊销-14,459,939.52-23,126,318.47
  长期待摊费用摊销-5,070,525.2-10,922,515.7
  处置固定资产、无形资产和其他长期资产的损失--181,184.53--520,328.84
  固定资产报废损失-63,789.76-601,655.43
  公允价值变动损失-2,121,027.02--73,356,424.42
  财务费用-58,015,991.81-103,652,681.68
  投资损失-2,818,891.75--23,153,668.53
  递延所得税--3,290,955.06--29,725,684.97
  其中:递延所得税资产减少--2,662,626.6--28,683,000.91
    递延所得税负债增加--628,328.46--1,042,684.06
  存货的减少--290,439,960.67--11,685,641.22
  经营性应收项目的减少-310,904,622.04-150,190,559.2
  经营性应付项目的增加--399,092,544.33-61,810,383.76
  现金的期末余额-1,697,575,165.59-1,912,084,455.36
  减:现金的期初余额-1,912,084,455.36-1,212,445,674.09
  加:现金等价物的期末余额-13,180,728.1-11,858,086.49
  减:现金等价物的期初余额-11,858,086.49-10,100,519.96
  现金及现金等价物的净增加额--213,186,648.16-701,396,347.8
公告日期2026-10-292026-08-292026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑